STATE STREET CORP - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 27 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,333
-34.2%
25,7740.0%0.00%
Q2 2023$29,382
-24.0%
25,7740.0%0.00%
Q1 2023$38,661
-49.7%
25,774
-50.0%
0.00%
Q4 2022$76,806
+92.0%
51,548
+100.0%
0.00%
Q3 2022$40,000
-32.2%
25,7740.0%0.00%
Q2 2022$59,000
-88.7%
25,774
-88.6%
0.00%
Q1 2022$521,000
-57.3%
225,572
+7.3%
0.00%
Q4 2021$1,220,000
-31.0%
210,292
+25.2%
0.00%
Q3 2021$1,768,000
+81.1%
168,031
+68.0%
0.00%
Q2 2021$976,000
+14.3%
100,000
+70.2%
0.00%
Q1 2021$854,00058,7710.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Alpha Wave Global, LP 213,658$3,104,0000.19%
Serengeti Asset Management LP 20,000$291,0000.13%
FORMULA GROWTH LTD 56,276$818,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 375,000$5,449,0000.12%
TUDOR INVESTMENT CORP ET AL 113,353$1,647,0000.03%
Duquesne Family Office 100,000$1,453,0000.03%
PURA VIDA INVESTMENTS, LLC 67,357$941,0000.03%
MOORE CAPITAL MANAGEMENT, LP 127,500$1,853,0000.02%
Zimmer Partners, LP 46,000$668,0000.01%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 26,000$376,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders